Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Deciphera Pharmaceuticals, Inc. (DCPH)  
$25.37 0.00 (0.00%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,930,000
Market Cap: 1.55(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.11 - $25.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. In addition, Co. has identified and developed various product candidates from its platform into clinical studies, including vimseltinib and DCC-3116. Co. is studying vimseltinib in a Phase 3 study in patients with tenosynovial giant cell tumor. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 21,000 1,687,666
Total Buy Value $0 $0 $291,244 $30,291,232
Total People Bought 0 0 2 3
Total Buy Transactions 0 0 2 3
Total Shares Sold 10,159 75,715 115,161 179,650
Total Sell Value $158,659 $1,108,986 $1,602,723 $2,646,007
Total People Sold 4 5 6 6
Total Sell Transactions 4 14 25 43
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 290
  Page 4 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2022-02-16 4 S $9.05 $12,362 D/D (1,366) 47,866 -48%     
   Martin Daniel C. Chief Commercial Officer   •       –      –    2022-02-16 4 S $9.05 $10,371 D/D (1,146) 48,668 -48%     
   Pitman Jama See Remarks   •       –      –    2022-01-18 4 A $0.00 $0 D/D 13,667 39,105     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2022-01-18 4 A $0.00 $0 D/D 20,500 49,216     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2022-01-18 4 A $0.00 $0 D/D 20,500 77,774     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2022-01-18 4 A $0.00 $0 D/D 20,500 49,232     -
   Martin Daniel C. Chief Commercial Officer   •       –      –    2022-01-18 4 A $0.00 $0 D/D 13,667 49,814     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2021-12-15 4 A $0.00 $0 D/D 11,100 28,732     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2021-12-15 4 A $0.00 $0 D/D 11,100 57,274     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2021-12-15 4 A $0.00 $0 D/D 11,100 28,716     -
   Martin Daniel C. Chief Commercial Officer   •       –      –    2021-12-15 4 A $0.00 $0 D/D 8,300 36,147     -
   Pitman Jama See Remarks   •       –      –    2021-12-15 4 A $0.00 $0 D/D 8,300 25,438     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2021-10-04 4 S $33.17 $88,199 D/D (2,659) 46,029 73%     
   Taylor Michael Douglas Director   –       •      –    2021-05-03 4 AS $46.07 $368,743 D/D (8,000) 0 -28%     
   Taylor Michael Douglas Director   –       •      –    2021-05-03 4 OE $1.89 $26,751 D/D 8,000 8,000     -
   Bristol James Arthur Director   –       •      –    2021-04-20 4 AS $45.60 $77,514 D/D (1,700) 0 -34%     
   Bristol James Arthur Director   –       •      –    2021-04-20 4 OE $3.95 $6,715 D/D 1,700 1,700     -
   Bristol James Arthur Director   –       •      –    2021-04-19 4 AS $46.13 $245,180 D/D (5,300) 0 -35%     
   Bristol James Arthur Director   –       •      –    2021-04-19 4 OE $3.95 $20,935 D/D 5,300 5,300     -
   Bristol James Arthur Director   –       •      –    2021-04-12 4 AS $43.70 $644,411 D/D (14,700) 0 -40%     
   Bristol James Arthur Director   –       •      –    2021-04-12 4 OE $3.95 $58,065 D/D 14,700 14,700     -
   Hoerter Steven L. President and CEO   •       •      –    2021-03-18 4 D $42.39 $135,500 D/D (3,150) 40,695     -
   Taylor Michael Douglas Director   –       •      –    2021-03-01 4 AS $43.94 $352,307 D/D (8,000) 0 -21%     
   Taylor Michael Douglas Director   –       •      –    2021-03-01 4 OE $1.89 $15,120 D/D 8,000 8,000     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2021-02-16 4 A $0.00 $0 D/D 11,100 48,386     -
  290 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us